Ablacon, Inc.
Works in Cardiovascular
Ablacon, Inc. is a clinical trial sponsor. It has no active clinical trials as lead sponsor; its trials since 2021 were in Cardiovascular. Since 2021 it has completed 2 trials and stopped 0 early.
Trial track record · since 2021
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
Questions about Ablacon, Inc
Ablacon, Inc has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 2 trials and stopped 0 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Ablacon, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-04-10.
Approve Suite is not affiliated with Ablacon, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.